Clinical relevance of plasma testosterone and prolactin changes in advanced cancer of prostate treated with diethylstilbestrol or estramustine phosphate
- 1 November 1985
- Vol. 26 (5) , 477-481
- https://doi.org/10.1016/0090-4295(85)90158-x
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Hormonal pattern in prostatic cancerActa Endocrinologica, 1981
- Hormonal Effects of Different Doses of Estramustine Phosphate (Estracyt®) in Patients with Prostatic CarcinomaScandinavian Journal of Urology and Nephrology, 1981
- Effects of Diethylstilbestrol and Estramustine Phosphate on Serum Sex Hormone Binding Globulin and Testosterone Levels in Prostate Cancer PatientsJournal of Urology, 1980
- Estramustine Phosphate in the Treatment of Advanced Prostatic CancerBritish Journal of Urology, 1980
- Treatment of Stage D Hormone-Resistant Carcinoma of the Prostate with Estramustine PhosphateJournal of Urology, 1979
- Hormone Changes in Patients with Prostatic Carcinoma, During Treatment with Estramustine PhosphateJournal of Urology, 1977
- Treatment of Advanced Prostatic Carcinoma with Estramustine Phosphate (Estracyt®)Scandinavian Journal of Urology and Nephrology, 1977
- PLASMA STEROID AND PROTEIN HORMONE CONCENTRATIONS IN PATIENTS WITH PROSTATIC CARCINOMA, BEFORE AND DURING OESTROGEN THERAPYActa Endocrinologica, 1976
- Treatment of Prostatic Carcinoma with Various Types of Estrogen DerivativesPublished by Elsevier ,1976
- Plasma prolactin, GH, LH, FSH, TSH and testosterone during treatment of prostatic carcinoma with oestrogensPublished by Elsevier ,1974